Foresite Capital Management II’s Alder Biopharmaceuticals ALDR Stock Holding History

Foresite Capital Management II’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-24,000	Closed	-$40K	–	13
2017 Q4	$40K	Buy	+24,000	New	+$268K	0.01%	11

Foresite Capital Management II's ALDR Position: Q4 2019 in Review

Foresite Capital Management II sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 146,800 shares — an estimated $2.77M sold.

Foresite Capital Management II first reported a position in ALDR in Q4 2014 and held it in 20 quarters. The position peaked at $26.6M in Q2 2018. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Foresite Capital Management II reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Foresite Capital Management II sold 146,800 Alder Biopharmaceuticals shares in Q4 2019, an estimated $2.77M.
Foresite Capital Management II first reported a position in Alder Biopharmaceuticals in Q4 2014 and held it in 20 quarters.
Foresite Capital Management II's Alder Biopharmaceuticals position peaked at $26.6M in Q2 2018.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Foresite Capital Management II's 13F filing for Q4 2019, filed 5 Feb 2020.